Keyword: Johnson & Johnson · 2 articles

Johnson & Johnson Reports Positive Phase 2 Nipocalimab Data Demonstrating Saliva Production Gains in Sjögren's Disease
11-08·665 words· …·Health Care
FDA Grants Accelerated Approval to J&J’s Rybrevant Faspro for Advanced Head and Neck Cancer
11-06·436 words· …·Health Care

Newest first. Keywords are assigned per article when written, grouping stories about the same event or subject.